Verheugt, Freek W.A.

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 8,943

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Dewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 1,719

Prevention of bleeding in patients with atrial fibrillation undergoing PCI

Gibson, C. M., Mehran, R., Bode, C., Halperin, J., Verheugt, F. W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., van Eickels, M., et al. (2016) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,590

Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–Thrombolysis in Myocardial Infarction 38

Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W. A., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., et al. (2008) · Circulation

Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research

Cited by 754

Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction

Zijlstra, F., Ernst, N., de Boer, M.-J., Nibbering, E., Suryapranata, H., Hoorntje, J. C. A., Dambrink, J.-H. E., van’t Hof, A. W. J., & Verheugt, F. W. A. (2002) · Journal of the American College of Cardiology

Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Cited by 131

Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial

Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W. A., & Morrow, D. A. (2010) · Circulation

Acute Myocardial Infarction ResearchCardiac electrophysiology and arrhythmias

Cited by 123

Clinical trial registration

Laine, C., Horton, R., DeAngelis, C. D., Drazen, J. M., Frizelle, F. A., Godlee, F., Haug, C., Hébert, P. C., Kotzin, S., Marusic, A., et al. (2007) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 98

Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation: A Randomized, Double-Blind, Placebo-Controlled Study

Enajat, M., Teerenstra, S., van Kuilenburg, J. T., van Sorge-Greve, A. H. N., Albers-Akkers, M. T. H., Verheugt, F. W. A., & Pop, G. A. M. (2009) · Drugs & Aging

Atrial Fibrillation Management and OutcomesLipoproteins and Cardiovascular Health

Cited by 13